Showing results (11-20 of 158) with videos related to

Sort By:
Pageof 16
Journal for Immunotherapy of Cancer|July 23, 2015
Update on checkpoint blockade therapy for lymphomaJustin Kline, Michael R Bishop
Therapeutic Advances in Hematology|February 18, 2020
Safety and efficacy of axicabtagene ciloleucel in refractory large B-cell lymphomasPeter A Riedell, Michael R Bishop
Emergency Medicine Clinics of North America|May 19, 2009
Emergencies related to cancer chemotherapy and hematopoietic stem cell transplantationDavid E Adelberg, Michael R Bishop
Clinical Lymphoma, Myeloma & Leukemia|June 11, 2011
Reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma: a concise reviewRachel B Salit, Michael R Bishop
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 17, 2013
Host lymphocyte depletion as a strategy to facilitate early full donor chimerism after reduced-intensity allogeneic stem cell transplantationRachel B Salit, Daniel H Fowler, Robert M Dean, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 11, 2026
Management of Bispecific Antibody Toxicities: A Focus on Multiple MyelomaEden Biltibo, Rajshekhar Chakraborty, Michael R Bishop
Current Opinion in Hematology|February 7, 2013
Expanded indications for allogeneic stem cell transplantation in patients with myeloid malignanciesHongtao Liu, Wendy Stock, Michael R Bishop
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 5, 2010
Minimal residual disease following allogeneic hematopoietic stem cell transplantationNicolaus Kröger, Koichi Miyamura, Michael R Bishop
Therapeutic Advances in Hematology|February 17, 2017
Emerging role of checkpoint blockade therapy in lymphomaNatalie Galanina, Justin Kline, Michael R Bishop
Pageof 16